熱門資訊> 正文
Lunai Bioworks将实施10：1反向股票分割
2025-09-25 04:59
- Lunai Bioworks (NASDAQ:RENB) announced on Wednesday that the company's Board of Directors has approved a 10:1 reverse stock split of its issued and outstanding common stock, to be effective on September 30, 2025.
- The company's common stock will trade on Nasdaq under the symbol "LNAI" following the reverse stock split, with a new CUSIP number of 29350E 203.
- The company expects its common stock to open for trading on a post-split basis on Nasdaq as of the commencement of trading on September 30, 2025.
- The reverse stock split is expected to reduce the number of shares of the company's common stock outstanding from approximately 231,780,434 shares to approximately 23,178,096 shares subject to some variability as a result of the fractional upward adjustments.
- RENB -24.68% after hours to $0.13.
- Source: Press Release
More on Lunai Bioworks Inc.
- Financial information for Lunai Bioworks Inc.
推薦文章
美股機會日報 | 金價再度走弱！現失守4030美元；中美貿易爭端緩和，納指期貨漲超1%
IBM、AMD雙雙大漲近8%！量子計算概念再起飛，下一個贏家是誰？
新股暗盤 | 滴普科技漲近50%，中籤一手賬面浮盈2660港元
新股暗盤 | 八馬茶業漲79.00%，中籤一手賬面浮盈3950港元
美股波動中的穩健長跑選手：華爾街押注Pinterest(PINS.US)、Uber(UBER.US)與通用汽車(GM.US)
黃金火爆行情帶熱招聘市場 對衝基金、貿易商高薪爭奪交易人才
迷霧中前行！美聯儲本周料將再度降息 內部分歧恐進一步加劇？
新股申購 | 「首家A+H豪華新能源車企」賽力斯今起招股，一手入場費13282.62港元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
